Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G)

被引：3
|
作者：
Guo, Xiaoling [1 ,2 ,3 ]
Zhang, Xufei [1 ,2 ,3 ]
Wang, Linlin [1 ,2 ,3 ]
He, Lingyun [1 ,2 ,4 ]
Ding, Yinjuan [1 ,2 ,3 ]
Chen, Huihui [1 ,2 ,3 ]
Wang, Dexuan [1 ,2 ,3 ]
Rong, Xing [1 ,2 ,3 ]
Shen, Xian [1 ,2 ,4 ]
Lin, Jian [1 ,2 ,5 ]
Chu, Maoping [1 ,2 ,3 ]
机构：
[1] Wenzhou Med Univ, Ctr Sci Res, Affiliated Hosp 2, 109 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Pediat, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 51卷
关键词：
D O I：
10.1016/j.scr.2021.102159
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The mutations of polyglutamine binding protein 1 gene (PQBP1) can lead to the rare inherited X-linked Renpenning syndrome (X-RSY). Here, an induced pluripotent stem cell (iPSC) line WMUi017-A was generated through reprogramming the urine cells of a 5-year-old male X-RSY patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G) using the commercial Sendai virus reprogramming system. The established iPSCs can stably express pluripotent stem cell markers OCT4 and NANOG, and can be induced into three germ layers and maintain a normal karyotype (46, XY) in vitro.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient
    Guo, Xiaoling
    Ji, Weiping
    Niu, Chao
    Ding, Yinjuan
    Chen, Zhanguo
    Chen, Congde
    Tong, Hongfei
    Han, Zhao
    Chu, Maoping
    STEM CELL RESEARCH, 2020, 49
  • [2] Generation of an urine-derived induced pluripotent stem cell line from a 6-year old X-linked adrenoleukodystrophy (X-ALD) patient
    Wang, Long
    Gao, Beibei
    Mo, Xuming
    Guo, Xiaoling
    Huang, Jinyu
    STEM CELL RESEARCH, 2021, 51
  • [3] Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A)
    Fuchs, Nina V.
    Schieck, Maximilian
    Neuenkirch, Michaela
    Tondera, Christiane
    Schmitz, Heike
    des Portes, Vincent
    Germanaud, David
    Steinemann, Doris
    Gohring, Gudrun
    Konig, Renate
    STEM CELL RESEARCH, 2019, 41
  • [4] Establishment of an induced pluripotent stem cell line (WMUi016-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p.R718*(c.2152C > T) in the CLCN5 ge ne
    Chen, Huihui
    Ding, Yinjuan
    Zhou, Weizhong
    Li, Jiajia
    Qian, Weite
    Zhang, Zhe
    Li, Chao
    Tong, Hongfei
    Rong, Xing
    Chu, Maoping
    Chen, Congde
    Wang, Dexuan
    Guo, Xiaoling
    STEM CELL RESEARCH, 2021, 51
  • [5] Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene
    Mao, Shengru
    Sun, Xihao
    Duan, Chunwen
    Jiang, Bing
    Ma, Hongjie
    Ji, Shangli
    Liang, Yuqin
    Zhang, Ruting
    Chen, Jiansu
    Tang, Shibo
    STEM CELL RESEARCH, 2023, 73
  • [6] Generation of an induced pluripotent stem cell line from an Ohtahara syndrome patient with the hemizygous mutation p.Q503Afs*28 (c.1507_1508del) in the ARX gene
    Wang, Chunmei
    Wang, Yilin
    Xu, Wuhen
    Lin, Xuefeng
    Xi, Jiaming
    Wang, Simei
    Lin, Longlong
    Yuan, Fang
    Wang, Anqi
    Wang, Chao
    Luo, Xiaona
    Xu, Quanmei
    Yin, Rongrong
    Zhang, Yuanfeng
    Huang, Xiaoyi
    Chen, Yucai
    STEM CELL RESEARCH, 2022, 59
  • [7] Generation of induced pluripotent stem cell (iPSC) line ZOCi003-A derived from peripheral blood mononuclear cells of X-linked juvenile retinoschisis harboring a hemizygous mutation in RS1 gene
    Liu, Yafen
    Liu, Xinyu
    Huang, Mingwei
    Zhang, Linyan
    Lu, Jinglin
    Zhang, Zhaotian
    Ding, Xiaoyan
    STEM CELL RESEARCH, 2021, 57
  • [8] Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X -linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene
    Sun, Lei
    Zhang, Jing
    Kuang, Xin-yu
    Kang, Yu-lin
    Wu, Ying
    Huang, Wen-yan
    STEM CELL RESEARCH, 2020, 45
  • [9] An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene
    Yang, Shu
    Cheng, Yu-Shan
    Li, Rong
    Pradhan, Manisha
    Hong, Junjie
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matt
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 39
  • [10] Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene
    Ji, Weiping
    Wang, Dexuan
    Chen, Congde
    Chen, Huihui
    Ding, Yinjuan
    Li, Chao
    Rong, Xing
    Shan, Xiaoou
    Chu, Maoping
    Shen, Xian
    Guo, Xiaoling
    STEM CELL RESEARCH, 2021, 52
12345